Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis

Abstract

A major obstacle in cancer gene therapy is selective tumor delivery. Previous studies have suggested that genetically engineered anaerobes of the genus Clostridium might be gene therapy vectors because of their ability to proliferate selectively in the hypoxic/necrotic regions common to solid tumors. However, the tumor colonization efficiency of the strain previously used was insufficient to produce any antitumor effect. Here we describe for the first time the successful transformation of C. sporogenes, a clostridial strain with the highest reported tumor colonization efficiency, with the E. coli cytosine deaminase (CD) gene and show that systemically injected spores of these bacteria express CD only in the tumor. This enzyme can convert the nontoxic prodrug 5-fluorocytosine (5-FC) to the anticancer drug 5-fluorouracil (5-FU). Furthermore, systemic delivery of 5-FC into mice previously injected with CD-transformed spores of C. sporogenes produced greater antitumor effect than maximally tolerated doses of 5-FU. Since most human solid tumors have hypoxic and necrotic areas this vector system has considerable promise for tumor-selective gene therapy.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Minton N.P. et al. Chemotherapeutic tumour targeting using clostridial spores FEMS Microbiol Rev 1995 17: 357 357

    Article  CAS  PubMed  Google Scholar 

  2. Fox M.E. et al. Anaerobic bacteria as a delivery system for cancer gene therapy: activation of 5-fluorocytosine by genetically engineered clostridia Gene Therapy 1996 3: 173 173

    CAS  PubMed  Google Scholar 

  3. Lemmon M.L. et al. Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment Gene Therapy 1997 4: 791 791

    Article  CAS  PubMed  Google Scholar 

  4. Malmgren R.A., Flanigan C.C. . Localization of the vegetative form of Clostridium tetani in mouse tumors following intravenous spore administration Cancer Res 1955 15: 473 473

    CAS  PubMed  Google Scholar 

  5. Möse J.R., Möse G. . Onkolyseversuche mit apathogenen anaeroben Sporenbildern am Ehrlich Tumor des Maus Z Krebsforsch 1959 63: 63 63

    Article  Google Scholar 

  6. Möse J.R., Möse G. . Oncolysis by clostridia. I. Activity of Clostridium butyricum (M-55) and other nonpathogenic clostridia against the Ehrlich carcinoma Cancer Res 1964 24: 212 212

    Google Scholar 

  7. Thiele E.H., Arison R.N., Boxer G.E. . Oncolysis by clostridia. III. Effects of clostridia and chemotherapeutic agents on rodent tumors Cancer Res 1964 2: 222 222

    Google Scholar 

  8. Engelbart K., Gericke D. . Oncolysis by clostridia V. Transplanted tumors of the hamster Cancer Res 1954 24: 239 239

    Google Scholar 

  9. Carey R.W. et al. Clostridial oncolysis in man Eur J Cancer 1967 3: 37 37

    Article  Google Scholar 

  10. Heppner F., Mose J.R. . The liquefaction (oncolysis) of malignant gliomas by a non-pathogenic clostridium Acta Neurol 1978 12: 123 123

    Google Scholar 

  11. Heppner F., Mose J., Ascher P.W., Walter G. . Oncolysis of malignant gliomas of the brain 13th Int Cong Chemother 1983 226: 38 38

    Google Scholar 

  12. Kievit E. et al. Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts Cancer Res 1999 59: 1417 1417

    CAS  PubMed  Google Scholar 

  13. Lawrence T.S. et al. Preferential cytotoxicity of cells transduced with cytosine deaminase compared to bystander cells after treatment with 5-flucytosine Cancer Res 1998 58: 2588 2588

    CAS  PubMed  Google Scholar 

  14. Krasnykh V. et al. Advanced generation adenoviral vectors possess augmented gene transfer efficiency based upon coxsackie adenovirus receptor-independent cellular entry capacity Cancer Res 2000 60: 6784 6784

    CAS  PubMed  Google Scholar 

  15. Xu L. et al. Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts Hum Gene Ther 1999 10: 2941 2941

    Article  CAS  PubMed  Google Scholar 

  16. Pawelek J.M., Low K.B., Bermudes D. . Tumor-targeted Salmonella as a novel anticancer vector Cancer Res 1997 57: 4537 4537

    CAS  PubMed  Google Scholar 

  17. Low K.B. et al. Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo Nat Biotechnol 1999 17: 37 37

    Article  CAS  PubMed  Google Scholar 

  18. Fabricius E.M. et al. Quantitative investigations into the elimination of in vitro-obtained spores of the non-pathogenic Clostridium butyricum strain CNRZ 528, and their persistence in organs of different species following intravenous spore administration Res Microbiol 1993 144: 741 741

    Article  CAS  PubMed  Google Scholar 

  19. Gericke D. et al. Further progress with oncolysis due to apathogenic clostridia Zentralbl Bakteriol 1979 243: 102 102

    CAS  Google Scholar 

  20. Streilein J.W. . Unraveling immune privilege Science 1995 270: 1158 1158

    Article  CAS  PubMed  Google Scholar 

  21. Hirst D.G., Brown J.M., Hazlehurst J.L. . Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain Br J Cancer 1982 46: 109 109

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Minton N.P. et al. Clostridial cloning vectors Woods DR (eds); The Clostridia and Biotechnology Butterworth-Heinemann 1993 pp 119–150

  23. Oultram J.D. et al. Introduction of plasmids into whole cells of Clostridium acetobutylicum by electroporation FEMS Microbiol Letts 1988 56: 83 83

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by USPHS grant CA 64697 awarded to JMB from the US National Cancer Institute and funds to NPM from the UK Department of Health.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, SC., Minton, N., Giaccia, A. et al. Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis. Gene Ther 9, 291–296 (2002). https://doi.org/10.1038/sj.gt.3301659

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301659

Keywords

This article is cited by

Search

Quick links